Notice 2 Apr 2025 government, regulatory notice, national science foundation, meeting schedule

📅Notice of Change in National Science Foundation Meeting Schedule

The National Science Foundation has announced a change in the scheduling of its upcoming Sunshine Act meeting, originally set for April 1, 2025. The meeting is now rescheduled to April 9, 2025. For further inquiries, Chris Blair is the designated point of contact.

Learn More
Notice 1 Apr 2025 sunshine act, federal election commission, regulatory notice, meeting announcement

🗓️Federal Election Commission Sunshine Act Meeting Notice

The Federal Election Commission announces a meeting under the Sunshine Act, detailing the previously scheduled time and discussing additional items, including a draft advisory opinion related to the Government Accountability Institute. This notice is aimed at informing the public and stakeholders about the upcoming meeting and its agenda.

Learn More
Notice 28 Mar 2025 drug abuse, regulatory notice, national institutes of health, meeting cancellation

📅Cancellation Notice of National Institute on Drug Abuse Meeting

The Department of Health and Human Services has officially canceled the scheduled meeting for the National Institute on Drug Abuse Special Emphasis Panel. No rescheduling will occur, and the cancellation notice follows a previously published announcement. The meeting was set to take place in April 2025 at the NIH headquarters in Bethesda, MD.

Learn More
Notice 28 Mar 2025 regulatory notice, civil rights, guam, u.s. commission on civil rights, public briefing

📢Public Briefing Notice for Guam Advisory Committee on Civil Rights

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Guam Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a virtual, public briefing via Zoom at 9:30 a.m. ChST on Thursday, April 10, 2025 (7:30 p.m. ET on Wednesday, April 9, 2025). The purpose of this briefing is to hear testimony on the topic, Overrepresentation of FAS Members in the Criminal Justice System on Guam.

Learn More
Notice 28 Mar 2025 public meeting, regulatory notice, civil rights, louisiana, mental health

🗣️Notice of Louisiana Advisory Committee Public Meeting on Mental Health

Notice is hereby given, pursuant to the provisions of the rules and regulations of the U.S. Commission on Civil Rights (Commission) and the Federal Advisory Committee Act, that the Louisiana Advisory Committee (Committee) to the U.S. Commission on Civil Rights will hold a public meetings via Zoom. The purpose of this meeting is for the Committee to review and discuss a project proposal regarding involuntary mental health commitments in Louisiana.

Learn More
Notice 27 Mar 2025 compliance, pharmaceuticals, regulatory notice, controlled substances, drug enforcement, import application

⚖️Restek Corporation's Import Application for Controlled Substances Notice

Restek Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.

Learn More
Notice 26 Mar 2025 healthcare, grants, nih, regulatory notice, diabetes research

💉Notice of Closed Meeting for Diabetes Research Grants Evaluation

The Department of Health and Human Services announces a closed meeting by the National Institutes of Health to review grant applications related to diabetes, digestive, and kidney diseases. The meeting, which will occur virtually, aims to protect sensitive information, including potential trade secrets and personal privacy concerns, making it closed to the public.

Learn More
Notice 26 Mar 2025 drug abuse, grant opportunities, health, regulatory notice, national institutes of health

💰NIH Notice on Closed Meetings for Drug Abuse Grant Applications

The Department of Health and Human Services announces closed meetings by the National Institute on Drug Abuse to review grant applications. This notice ensures confidentiality on sensitive discussions pertaining to trade secrets and personal information, emphasizing the importance of privacy in the evaluation process for potential funding in drug abuse research initiatives.

Learn More
Notice 25 Mar 2025 regulatory notice, advisory board, department of defense, air force

🚫Air Force Advisory Board Meeting Withdrawn – Regulatory Notice

The previous Department of the Air Force Scientific Advisory Board Federal Register Notice, Vol. 90, No. 12154, published on Friday March 14, 2025, is hereby withdrawn. The Department of the Air Force Scientific Advisory Board Meeting to be held on March 27-28, 2025 is cancelled. The Department of the Air Force Scientific Advisory Board has been directed to pause all operations for 45 days effective Friday, March 7, 2025, Office of the Secretary of Defense memorandum, "Review of Department of Defense Advisory Committees".

Learn More
Notice 25 Mar 2025 grants, nih, health, regulatory notice, business opportunities, neuroscience

🧠NIH Meeting Notice

The Department of Health and Human Services announces a closed meeting of the National Advisory Neurological Disorders and Stroke Council to review grant applications and discuss initiatives. The meeting is intended for evaluating submissions that could impact research in neurological disorders, with confidentiality provisions in place to protect sensitive information.

Learn More